Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
Son Y, Lim D, Park S, Song IS, Kim JH, Shin S, Jang H, Liu KH, O Y, Song GY, Kang W, Cho YS, Na M, Chung H, Oh S.
Son Y, et al. Among authors: chung h.
Pharmacol Res. 2020 Nov;161:105146. doi: 10.1016/j.phrs.2020.105146. Epub 2020 Aug 16.
Pharmacol Res. 2020.
PMID: 32814173